ABSTRACT
INTRODUCTION
Foot-and-mouth disease (FMD is an acute, febrile, and contagious vesicular disease affecting cloven-hoofed animals. The causal agent, FMD virus (FMDV), is a member of the genus Aphthovirus in the family Picornaviridae and occurs as seven distinct serotypes throughout the world: A, O, C, Asia1 and South African Territories (SAT) 1-3 [1] [2] [3] . Vaccination is the most important control and eradication strategy for FMD, especially the oil-adjuvant vaccine in developing countries. Significant advances in recent years have led to the introduction of ''ready-toformulate" oil adjuvants. Montanide ISA 206, the mineral based oil, which readily forms water-in-oil-in-water emulsion. Its efficacy in eliciting immune response was studied in FMD vaccines against FMDV [4] [5] [6] [7] .
The advantage of oil adjuvant was attributed to depot formation at the site of injection, a vehicle for transport of the antigen throughout the lymphatic system and slow antigen release with the stimulation of antibody producing cells. Moreover, being oil emulsion, Montanide ISA 206 had various advantages, like low viscosity, easy administration, longer term protection, greater stability and production of smaller nodules at the site of injection [5] , compared to other oil adjuvants, making as an ideal adjuvant candidate for FMD vaccines. It was also suggested that Montanide ISA 206 could prevent the loss of potency was due to the proteolysis of VP1 or possibly the physical breakdown of the virus followed adsorption to the aluminum hydroxide gel [8] and agree with the usage of Montanide ISA 206 ready to formulate oil adjuvant can be sued in all target species is ideal for emergency vaccination [9] . The usage of oil adjuvant (Montanide ISA 206) improve, enhance cell mediated immunity and give higher level and long lasting immunity [10, 11] . Other researchers [12, 13] detected that DOE vaccine containing Montanide ISA 206 is highly efficient, fluidy with low viscosity which is easily dispersed from the place of injection and gave high Ab titers and longest duration of immunity than alhdyragel vaccine and Daoud reported that the duration of immunity elicited by gel FMD vaccine was short lived and antibody concentrations rapidly fall after administration, while oils adjuventated FMD vaccines gave a longer duration of immunity and suggested that the oil adjuvenated vaccines had potential as an alternative to the conventional aluminum hydroxide FMD vaccine [14] . Moreover Patil reported that the oil adjuvant elicited a better immune response at any time than did aluminum hydroxide gel FMD quadrivalent vaccines in goats, and the response developed quicker. Local tissue reactions such as granulomas and cysts to oil-adjuvants have been not detected [15] . 
MATERIALS & METHODS

The Animals
Fifty 2-month-old pigs, sero-negative for FMDV type O antibodies (titre 1:4 by LPB-ELISA) were randomly divided into four groups. 45 pigs in group 1-3 and 15 pigs in each group. The vaccine with ISA 206 was the first group. The vaccine with ISA 201 was the second group. The vaccine with PBS as the adjuvant was the third group. Three small groups (Five pigs in it) were divided in each group for three vaccine dose 2.0 ml (1/1 full dose), 0.67 ml (1/3 full dose), 0.22 ml (1/9 full dose) to determine the PD50 (protective dose 50%). The left five pigs were in the 4th group as the control. All the pigs were bred in the P3 animal laboratory respectively.
Vaccine Preparation
The FMDV type O antigen was inactivated and safety checked by conventional method, and emulsified with ISA 201 or ISA 206 separately according to the prospectus guide. The vaccine was stored at 4˚C.
Vaccination, Sera Collection and Virus Challenge
Three types of FMD vaccines were intramuscular inoculated at the ear-root-neck area of 45 pigs with 2 ml, 0.67 ml, 0.22 ml inactivated vaccine respectively, and five pigs were bred without vaccination as negative control. Blood and sera samples were collected at 0, 3, 7, 14, 21, 28 dpv (days post vaccination) to assay the FMDV type O antibody by LPB-ELISA. To demonstrate vaccine efficacy, all 50 pigs were challenged intramuscularly with 1000 PID 50/2 ml of FMDV type O suckling mice passaged strain at the ear-root-neck area after 28 dpv and FMD symptoms were monitored for 10 days, and the PD50 was calculated with Karber method.
THE RESULTS
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The ELISA Antibody Titer of FMDV Type O after Pigs Vaccinated
The ELISA antibody titer of 201-vaccine (1/1 dose) was 186.12 on 21st dpv, 201.82 on 28th dpv, much higher than which of 206-titer (p < 0.05), because the titer of 206-vaccine (1/1 dose) was 69.76 on 21st dpv, 57.28 on 28th dpv. The ELISA antibody titer of 201-vaccine (1/3 dose) was 133.48 on 21st dpv, 120.62 on 28th dpv, much higher than which of 206-titer r (p < 0.05), because the titer of 206-vaccine (1/3 dose) was 69.3 on 21st dpv, 71.96 on 28th dpv. The ELISA antibody titer of 201-vaccine (1/9 dose) was 65.54 on 21st dpv, 84.36 on 28th dpv, much higher than which of 206-titer r (p < 0.05), because the titer of 206-vaccine (1/9 dose) was 30.9 on 21st dpv, 29.56 on 28th dpv (Figure 1) . These data showed that the effect of 201-vaccine is better than 206-vaccine.
The FMD Virulent Virus Challenge to Immunized Pigs on 28dpv
The challenge result was presented in Table 1 . 
DISCUSS
The ISA206 adjuvant has applied in FMD vaccine production and other vaccines for 20 years, because it has lower side-reactions and viscosity, easier to emulsify and injection, and higher stability. Recently, The ISA 201 has developed on the base of ISA 206, which inherited advantages of ISA 206, and added some chemical substances with the hope of enhancing animals' cellular immune reactions [16] . In this report, the comparisons between ISA 201 and ISA 206 were done as the FMD vaccine respectively. First the ELISA antibodies against FMDV type O were compared. The antibody titer induced by 201-vaccine were higher than which of 206-vaccine on 3dpv, 7dpv, 14dpv, 21dpv, 28dpv. This means that the effect of 201-vaccine in inducing antibody is better than which of 206-vaccine.
The virus challenge trial to vaccinated animals is a very important index for evaluating the potency of FMD vaccine, which is indicated with PD50 (50 percent protection dose) [17, 18] . Here, fifty pigs were all protected immunized with 201 vaccine, but thirty pigs were protected with 206 vaccine, which means that the potency of 201 vaccine is better than that of 206 vaccine.
CONCLUSION
From above, the efficacy of the FMD vaccine emulsified with ISA 201 is superior to ISA 206.
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